Home › CANON INC. › TOSHIBA SUPERCONDUCTING MRI SYSTEM Vantage Elan
TOSHIBA SUPERCONDUCTING MRI SYSTEM Vantage Elan
CANON INC. · Model MRT-2020 · UDI-DI 04987670101632
3
510(k) clearances
4,751
Adverse events (37 deaths)
699
Recalls
145
Facilities
Description
This device was previously sold by TOSHIBA MEDICAL SYSTEMS CORPORATION under the brand name TOSHIBA SUPERCONDUCTING MRI SYSTEM Vantage Elan. Effective Jan 2018, the company name changed to CANON MEDICAL SYSTEMS CORPORATION. The device brand name is now Vantage Elan.
Recalls
| Date | Firm | Reason |
|---|---|---|
| 2026-04-14 | Philips North America | The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction |
| 2026-04-14 | Philips North America | The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction |
| 2026-04-14 | Philips North America | The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction |
| 2026-04-14 | Philips North America | The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction |
| 2026-04-14 | Philips North America | The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction |
| 2026-04-14 | Philips North America | The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction |
| 2026-04-14 | Philips North America | The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction |
| 2026-04-14 | Philips North America | The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction |
| 2026-04-14 | Philips North America | The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction |
| 2026-04-14 | Philips North America | The potential for stiffness value errors when a specific range of image reconstruction parameters is used in combination with Resoundant's algorithm, leading to the reconstruction |
Query this across every FDA database — by API.
Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.
Get your free API keyRead the docsData compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.